Mirum Pharmaceuticals, Inc. (MIRM) NASDAQ
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Mirum Pharmaceuticals, Inc.
Address
989 East Hillsdale Boulevard
Foster City, CA 94404
United States of America (the)
Phone
650 667 4085
Website
Sector
Healthcare
Industry
Biotechnology
Employees
433
First IPO Date
July 18, 2019
Key Executives
| Name | Title | Pay | Year Born |
| Christopher Peetz | Chief Executive Officer & Director | 1.83M | 1979 |
| Lara Longpre | Chief Development Officer | 678,200 | 1970 |
| Joanne J. Quan | Chief Medical Officer | 1M | 1964 |
| Eric H. Bjerkholt | Chief Financial Officer | 1M | 1960 |
| Peter Radovich | Chief Operating Officer & President | 1.16M | 1978 |
| Jean-Luc Girardet | Chief Technical Officer | 0 | N/A |
| Andrew McKibben | Senior Vice President, Strategic Finance & Investor Relations | 0 | N/A |
| Vinita Kumar | Senior Vice President of Quality | 0 | N/A |
| Meredith Kiernan | Senior Director of Global Corporate Communications | 0 | N/A |
| Erin Campany | Chief People Officer | 0 | 1968 |
| Douglas T. Sheehy | Chief Legal Officer & Secretary | 0 | 1967 |
Description
Mirum Pharmaceuticals, Inc. is a biopharmaceutical firm dedicated to discovering and commercializing groundbreaking therapies for serious rare and orphan conditions. Its lead experimental drug, LIVMARLI, an oral treatment, is currently undergoing trials for progressive familial intrahepatic cholestasis (PFIC), Alagille syndrome, and biliary atresia. Furthermore, the company is advancing Volixibat to address intrahepatic cholestasis of pregnancy and primary sclerosing cholangitis. Founded in 2018, Mirum Pharmaceuticals, Inc. operates from its headquarters in Foster City, California.
